← Back to Patent Explorer
US4479799A Expired / Lapsed US ⏱️ 0.0 years remaining

Hypodermic syringe containing microfibers of an amorphous heparin salt

Assignee: Riker Laboratories Inc
•
Filing: 1983-04-06
•
Granted: 1984-10-30
•
Expires: 2003-04-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Microfibrous heparin salts, nonwoven webs of such fibers, a process for preparing the fibers and the use of the webs for the rapid heparinization of blood are disclosed.

Inventors

  • 👤 Charles G. Thiel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 12:01
CPC Classifications
D; D01; D01F; D01F9/00; C; C08; C08L; C08L5/00; C08L5/10; D04; D04H; D04H1/00; D04H1/40; D04H1/54; D04H1/56

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 26 words
A hypodermic syringe containing a quantized amount of microfibers of an amorphous heparin salt which have an average length to diameter ratio of at least 20.
Claim 2
Dependent Claim 26 words
A hypodermic syringe containing a quantized amount of microfibers of an amorphous heparin salt which have an average length to diameter ratio of at least 20.
Claim 3
Dependent Claim 28 words
A hypodermic syringe according to claim 1 wherein the microfibers have a density of about 1.8 g/cc and an average length to diameter ratio of at least 80.
Claim 4
Dependent Claim 29 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is selected from groups I and II of the periodic table of the elements.
Claim 5
Dependent Claim 17 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is sodium.
Claim 6
Dependent Claim 17 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is calcium.
Claim 7
Dependent Claim 17 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is magnesium.
Claim 8
Dependent Claim 17 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is zinc.
Claim 9
Dependent Claim 17 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is potassium.
Claim 10
Dependent Claim 17 words
A hypodermic syringe according to claim 1 wherein the cation of the amorphous heparin salt is lithium.

References Cited (Backward Citations)

GB899329A Cited
US3634123A Cited
US3673612A Cited
US4168377A Cited
US4178941A Cited
US4234652A Cited
US4048064A Cited
US4073723A Cited
US4203891A Cited
DE2806515A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-10-30 1988-04-30 1988-10-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-10-30 1992-04-30 1992-10-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-10-30 1996-04-30 1996-10-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag